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Introduction
Neurogenic inflammation is regarded as a first line of defense 
and protects tissue integrity when noxious conditions threaten 
normal body functions (Thorning et al 1982; Richardson and 
Vasko 2002; Birklein and Schmelz 2008). However, severe or 
prolonged noxious stimulation may result in the inflamma-
tory response mediating injury rather than facilitating repair. 
Airway neurogenic inflammation is caused by neuropeptides 
released from peripheral nerve endings of sensory neurons 
within the airways, and is characterized by plasma protein 
extravasation, airway smooth muscle contraction, and ele-
vated mucus secretion (Nadel 1991; Barnes 1996). In vivo the 
concentration of released neuropeptides depends on both 
release and degradation of enzymes, and Neutral endopepti-
dase (NEP) is the principal degradative enzyme. NEP cleaves 
peptide bonds on the amino side of hydrophobic amino acid 
residues,  leading  to  inactive  fragments.  NEP  is  present  in 
lungs, brain, intestine, and bone marrow (Roques et al. 1993).
In the lung, NEP is abundantly expressed in epithelial cells 
(Johnson et al. 1985). Inhibition of NEP by thiorphan or phos-
phoramidon leads to increased secretion of NEP (Edwards et 
al. 1999). In several cases NEP is secreted by cells that have 
tachykinin  receptors.  The  key  role  of  NEP  in  limiting  and 
regulating the neurogenic inflammation provoked by differ-
ent stimuli has been demonstrated in multiple recent stud-
ies (Nadel 1991; Maria et al. 1998; Chung 2006). It has been 
shown that a variety of factors that stimulate clinically rele-
vant airway inflammation, including viral infections, allergen 
exposure, inhalation of cigarette smoke, and other respiratory 
irritants, also reduce NEP activity, thus enhancing the effects 
of neuropeptides within the airways. The degradative activity 
of NEP is not limited to neuropeptides, but also affects other 
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Abstract
The effects of neutral endopeptidase (NEP) in acute inflammation in the lung were studied using a newly devel-
oped murine model of smoke and burn (SB) injury. C57BL/6 mice were pretreated with an i.v. dose of a specific 
NEP antagonist CGS-24592 (10 mg/Kg) 1 h prior to SB injury (n = 5–8/group). Mice were anesthetized with i.p. 
ketamine/xylazine, intubated, and exposed to cooled cotton smoke (2 × 30 s). After s.c. injection of 1 ml 0.9% 
saline, each received a 40% total body surface area (TBSA) flame burn. Buprenorphene (2 mg/kg) was given i.p. 
and resuscitated by saline. Evans Blue dye (EB) was injected i.v. 15 min before sacrifice. Lung wet/dry weight ratio 
was measured. After vascular perfusion, lungs were analyzed for their levels of EB dye and myeloperoxidase 
(MPO). In mice pretreated with CGS-24592 followed by SB injury the EB levels were significantly higher (61%, 
p = 0.043) than those with SB injury alone. There was a significant increase (144%, p = 0.035) in EB dye in animals 
with SB injury alone as compared to shams. In mice pretreated with CGS-24592 prior to SB injury wet/dry weight 
ratios were significantly (27%, p = 0.042) higher compared to animals with SB injury alone. CGS-24592 pretreat-
ment also caused a significant increase in MPO (29%, p = 0.026) as compared to mice with SB injury alone. In 
conclusion the current study indicates that specific NEP inhibitor CGS 24592 exacerbates the SB-induced lung 
injury and inflammation in mice.
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significant peptides including angiotensin II and brakykinin 
(Katayama et al. 1991; Turner et al 1993; Yang et al 1997).
Recent studies from this laboratory have demonstrated 
increased vascular permeability in a mouse model of com-
bined SB injury (Jacob et al. 2008). There was a significant 
(p < 0.05) increase in lung Evans Blue dye content, wet/dry 
weight ratio, and MPO content 24 and 48 h after SB injury in 
Balb/C and C57BL/6 mice, respectively, indicating increased 
plasma extravasation and edema.
On the basis of these observations, reduction of NEP activ-
ity may be regarded as part of a process that alters neurogenic 
airway responses from their physiological and protective func-
tion to a detrimental role that increases and perpetuates airway 
inflammation (Figure 4). Better knowledge of the regulation of 
the neurogenic pathway of airway inflammation would provide 
valuable information on the mechanism of acute lung injury. 
We hypothesized that inhibition of NEP would exacerbate SB 
injury, leading to more plasma extravasation and more severe 
airway inflammation. To test this, we studied whether block-
ing NEP with a specific inhibitor, CGS 24592, would increase 
vascular leakage and edema and inflammation.
Materials and methods
Animal preparation and treatment
Male C57BL/6 mice weighing 19–21 g (5–6 weeks old) were 
obtained  from  Charles  River  Laboratories  (Wilmington, 
MA). Mice were acclimatized to the animal facility for at least 
1 week before the experiments were started. All procedures 
have been reviewed and approved by the Animal Care and 
Use Committee of the University of Texas Medical Branch 
specifically for use in these research studies.
Tracheal intubation and cotton smoke exposure
Briefly, mice were anesthetized with i.p. injection of keta-
mine (50 mg/kg), and xylazine (10 mg/kg). Once adequately 
anesthetized,  mice  were  suspended  by  their  upper  inci-
sors on a custom made intubation stand that allows direct 
visualization of the mouse glottis. A 20 gauge plastic cannula 
with a Y-shaped adaptor was constructed from readily avail-
able parts and inserted into the trachea using a specially 
constructed laryngoscope made from an aluminum ‘mag 
light’  (Mag  Instrument  Inc.,  Ontario,  CA)  flashlight  fitted 
with a fiber optic illuminator, under direct vision using a 
head-mounted jeweler’s magnifier.
A custom-made miniature smoke generator was arranged 
so that smoldering cotton toweling could be kept burning by a 
regulated flow of air. Smoke emerging from a cooling coil was 
delivered through plastic tubing to the Y-connector attached 
to the endotracheal tube at near atmospheric pressure. A 
pressurized air source was attached to the smoke generation 
chamber to control the flow and density of smoke delivered 
to the Y-tube. Mice were allowed to breathe normally during 
smoke exposure. Mice were exposed to two 30-s intervals of 
smoke inhalation, breathing room air between exposures, 
followed by 48 h of reaction and recovery.
Burn injury
After  smoke  exposure,  the  back  and  bilateral  flanks  of 
each mouse were shaved, and 0.9 ml of normal saline was 
injected subcutaneously along the vertebral column. This 
subcutaneous  liquid  prevents  thermal  injury  to  internal 
organs such as the spinal cord and liver (Stephenson et 
al. 1975). A Zetex cloth with a square window was placed 
over each mouse during the burning procedure to prevent 
thermal injury to other structures and to confine the burn 
area. Each mouse received a brief (less than 10 s) exposure 
to a Bunsen burner flame. The flame was applied just long 
enough to induce retraction of the skin. The Zetex window 
allows for administration of a 40% total body surface area, 
full thickness burn.
Mice were resuscitated with normal saline (4 ml/kg/% 
TBSA burn, i.p.). The endotracheal tube was removed as 
the  mice  recovered.  Animals  were  given  a  daily  dose  of 
buprenorphene (0.1 mg/kg, i.p.) starting immediately after 
the injury for post-procedure analgesia. At the end of the 
experimental time period, mice were killed by isoflurane 
overdose followed by cervical dislocation. Histologic study 
demonstrated  full  thickness  dermal  injury  and  showed 
no signs of necrosis or other recognizable changes in the 
portion of the liver under the site of injury. Sham control 
animals were anesthetized and intubated in the same man-
ner as experimental animals, but were allowed to breathe 
room air rather than given smoke exposure. They were also 
shaved and injected along their spines with saline, but not 
burned. The sham control mice received the same volume 
of saline resuscitation and the same routine analgesia as the 
animals injured by burn and smoke inhalation. In addition, 
mice were studied for comparison with the sham animals 
that were not intubated or shaved or injected with saline 
(‘untouched’ control animals).
Preparation and administration of drug
The  specific  NEP  inhibitor  (CGS  24592;  (S)-N-[2-
(phosphonomethylamino)-3-(4-biphenylyl)-propionyl]-
Figure 1.  Proposed pathway for the role of NEP in lung injury following 
SB injury in mice. Initial neurogenic inflammation induced by SB induced 
noxious stimuli will be prolonged and intensified due to decrease or lack of 
NEP, causing excessive plasma leakage, edema and neutrophil infiltration.
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3-aminopropionic acid) was kindly provided by Novartis 
(Cambridge,  MA).  CGS  24592  was  prepared  at  1 mg/mL 
in  sodium  bicarbonate  buffer  and  sterilized  through  a 
0.22-m filter and kept frozen until use. The drug was dis-
solved in HPLC grade H2O at the concentration of 10−3 M, 
filtered through a 0.22-µm filter (Millipore), and stored at 
−70°C. Mice were treated i.v. at a dose of 10 mg/kg 1 h prior 
to SB injury and then every 24 h over the 48-h period.
Tissue sampling
Animals were deeply anesthetized at 48 h after SB injury, the 
chest of each mouse was opened, and a median sternotomy 
was performed. The lungs were excised in one block and 
the  left  and  right  lungs  were  separated.  Both  lungs  were 
snap-frozen in liquid nitrogen for determination of wet/dry 
weight ratio.
Evans Blue extravasation
Sham and SB injured mice were injected with Evans Blue 
dye (EB, 20 mg/kg) via the tail vein 30 min before the termi-
nation of the experiment to assess vascular leakage (Wang et 
al. 2002). After perfusion of the lungs with PBS as described 
previously (Jacob et al. 2008), the lungs were excised en bloc 
and dried on filter paper. After weighing, the lung tissue was 
snap frozen in liquid nitrogen and stored at −80°C. At the 
time of assay, lung tissue was manually homogenized using 
a bead beater (Biospec Products, Bartlesville, OK) and incu-
bated with two volumes of formamide (Fisher Scientific, Fair 
Lawn, NJ) for 18 h at 60°C. The supernatant was collected 
after centrifugation at 5000 g for 30 min. The optical density 
of the supernatant was determined spectrophotometrically 
at a wavelength of 620 nm. Levels of EB in samples were 
quantitated using a standard curve prepared with known 
amounts of EB, and the data are expressed as nanograms 
EB/mg lung.
Wet-to-dry-weight ratio
Lungs were removed and placed in preweighed glass vials, 
then dried for 48 h in an oven at 65°C and reweighed, using 
a balance capable of indicating the weight to the nearest 
0.1 mg, to determine the ratio of wet-to-dry weight, a meas-
ure of total tissue water content (Zhao et al. 2006).
Determination of myeloperoxidase
Sequestration of polymorphonuclear neutrophils (PMNs) 
indicated  by  MPO  activity  was  measured  in  lung  tissue 
homogenates  using  an  MPO-EIA  kit  (Oxis  Inc,  Portland, 
OR), following the manufacturer’s protocol. Briefly, lungs 
were perfused with PBS as described earlier and homog-
enized in TBS-T buffer using a bead beater and centrifuged 
at 13,000 g for 20 min. The protein content of the superna-
tant was assessed using the Bradford assay (Bradford 1976). 
To assess MPO, 100 l of the supernatant was added to 
the micro wells in triplicate and incubated for 1 h at room 
temperature. Plates were washed using washing buffer and 
diluted anti-MPO was added to each well. After 30 min incu-
bation, plates were washed and avidin alkaline phosphatase 
was added followed by p-nitrophenol phosphate (pNPP) 
solution. The reaction was allowed to develop a pale yel-
low color for 30 min and was then terminated by adding 
50  l  stop  solution,  and  absorbance  was  immediately 
read at 405 nm using a TECAN-GENios microplate reader 
(Durham, NC). Myeloperoxidase activity was quantitated 
using a standard curve with known amounts of MPO, taking 
care that samples were compared to the linear portion of 
the standard curve.
Statistical analysis
Values are shown as the mean ± SE of at least five deter-
minations  (n = 5).  Statistical  significance  of  the  results 
was  conducted  by  one-way  analysis  of  variance  followed 
by Dunnette’s post-hoc test. The level of significance in all 
experiments was defined as p < 0.05.
Results
Plasma extravasation in mouse lung
Levels of EB were quantitated in mice pretreated with spe-
cific NEP antagonist CGS 24592 followed by SB injury. The 
data indicate significantly higher (62%, p = 0.043) levels of 
EB in NEP antagonist pretreated and SB injured mice as 
compared to untreated animals with SB injury at 48 h after 
injury (Figure 1). As expected, Evans Blue dye levels were 
also significantly (144%, p = 0.036) higher in SB injured mice 
as  compared  to  respective  sham  controls.  Pretreatment 
with CGS 24592 alone caused a significant increase (69%, 
p = 0.016) in EB levels as compared to respective sham ani-
mals pretreated with bicarbonate buffer.
Figure 2.  Effect of NEP antagonist pretreatment in plasma extravasation:   
A significant increase (**p = 0.0432) in EB levels was observed in NEP 
antagonist pretreated mice (Checked Bar, SB+C) 48 hr following SB injury 
compared to animals with SB injury alone   (SB ,black filled bar). EB lev-
els were also significantly (*p =0.0356) increased 48 hr following SB injury 
alone (black filled bar) compared to respective sham animals (open bar).   
Pretreatment with CGS 24592 alone (Sham + C, speckled bar) caused sig-
nificant increase (69%, p = 0.016)in EB levels as compared to respective 
sham animals pretreated only with the drug vehicle, bicarbonate buffer   
(Sham + V, dotted bar). EB levels were quantitated from an authentic stand-
ard curve with known concentrations of EB. Values are means ±SE of at 
least 5 mice/group.
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Lung wet/dry ratio
Wet/dry  weight  ratio  was  calculated  as  described  earlier. 
Wet–dry weight ratios were significantly elevated (27%, 0.043) 
in mice pretreated with CGS-24592 followed by SB injury as 
compared to corresponding SB control animals (Figure 2). 
The data also indicate that at 48 h following smoke and burn 
injury there was a significant increase (57%, 0.022) as com-
pared to sham animals. Pretreatment with CGS 24592 alone 
(Sham + C, speckled bar) caused a slight decrease in wet/
dry weight ratios as compared to respective sham animals 
pretreated with bicarbonate buffer. Sham animals showed 
an insignificant increase (32%, p = 0.137) in wet/dry weight 
ratio as compared to untouched control animals (data not 
shown).
Myeloperoxidase activity
Levels of MPO were determined using a sandwich ELISA 
kit as described, following thorough perfusion of the pul-
monary  arterial  system  with  normal  saline.  Because  the 
lungs underwent vascular perfusion prior to analysis, the 
determination of MPO includes neutrophils that are firmly 
adherent to pulmonary endothelium as well as those that 
have  extravasated  from  vessels.  In  mice  pretreated  with 
CGS24592  followed  by  SB  injury  there  was  a  significant 
increase  (29%,  p = 0.026)  in  MPO  levels  as  compared  to 
untreated mice with SB injury alone (Figure 3). As expected 
there was a significant increase in MPO levels in SB injured 
animals  compared  to  respective  sham  animals  (142%, 
p = 0.0056). Pretreatment with CGS 24592 alone (Sham + C, 
speckled bar) caused a slight insignificant increase in MPO 
activity as compared to respective sham animals pretreated 
with bicarbonate buffer.
Discussion
Following burn trauma, toxic smoke inhalation has been 
recognized  as  a  major  cause  of  mortality  (Crapo  1981). 
Previous  reports  from  this  and  other  laboratories  have 
indicated that toxic smoke causes progressive injury to the 
airways, followed by injury to lung parenchyma (Barrow 
et al. 1990; Dost 1991; Traber and Herndon 1991; Bidani et 
al. 1999). Even though rapid release of chemical mediators 
in the airways is a suggested mechanism for injury, there 
is limited understanding of the underlying processes that 
lead to delayed parenchymal injury. Neurogenic inflamma-
tion is regarded as a first line of defense and protects tissues 
when noxious conditions threaten normal body functions. 
However,  severe  or  prolonged  noxious  stimulation  may 
result in the inflammatory response mediating injury rather 
than facilitating repair (Day et al. 2005).
Plasma  extravasation  and  edema  are  secondary 
responses to neurogenic inflammation caused by release 
of substances such as substance P, calcitonin gene-related 
peptide  CGRP,  and  other  neuropeptides  from  primary 
sensory  nerve  terminals  (Solvay  and  Leff  1991;  Nadel 
1991; Richardson and Vasko 2002). The local concentra-
tion of released neuropeptides depends on both release 
and degradation, and the principal degradative enzyme 
is NEP, which is abundantly expressed in epithelial cells 
of  the  lung  (Johnson  et  al.  1985).  Multiple  factors  that 
stimulate clinically relevant airway inflammation, includ-
ing viral infections, allergen exposure, inhalation of ciga-
rette smoke, and other respiratory irritants, also reduce 
NEP activity, thus enhancing the effects of neuropeptides 
within  the  airways.  Previous  studies  have  indicated  the 
proinflammatory  effects  of  NEP  antagonists  including 
Figure 3.  Effect of NEP antagonist pretreatment on edema: A signifi-
cant increase (** p = 0.0425) in wet/ dry weight ratios was indicated in 
NEP antagonist pretreated mice (Checked Bar, SB+C) 48 hr following SB 
injury compared to animals with SB injury alone. (SB, black filled bar). 
Wet/ dry weight ratios were also significantly increased (*p = 0.0218) 48 
hr following SB injury alone (black filled bar) compared to respective 
sham animals (open bar). Pretreatment with CGS 24592 alone (Sham 
+ C, speckled bar) caused a slight decrease n wet/ dry weight ratios 
as compared to respective sham animals pretreated with bicarbonate 
buffer  (Sham + V, dotted bar). Values are means ±SE of at least 6 mice/
group.
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Figure 4.  Effect of NEP antagonist pretreatment on neutrophil infiltra-
tion and inflammation: A significant increase (**p = 0.0255) in MPO lev-
els was observed in NEP antagonist pretreated mice (Checked Bar, SB+C) 
48 hr following SB injury compared to animals with SB injury alone (SB, 
black filled). MPO levels were also significantly increased (*p =0.0045) 
48 hr following SB injury alone (black filled bar) compared to respective 
sham animals (open bars). MPO levels were quantitated from an authen-
tic standard curve with known amounts of MPO. Pretreatment with CGS 
24592 alone (Sham + C, speckled bar) caused a slight insignificant increase 
in MPO activity as compared to respective sham animals pretreated with 
bicarbonate buffer (Sham + V, dotted bar). Values are means ±SE of at least 
5 mice/group.
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the specific NEP inhibitor CGS 24592 (Damas et al. 1996; 
Pham et al. 2000; Nicolau et al. 2003). These agents caused 
plasma extravasation and vascular permeability in various 
animal models.
The current study was undertaken to examine whether 
inhibition  of  NEP  would  exacerbate  SB  injury  leading  to 
more plasma extravasation and more severe airway inflam-
mation. To test this, we studied whether blocking NEP with a 
specific inhibitor, CGS 24592, would increase vascular leak-
age, edema, and inflammation.
The current study indicates that NEP inhibition by CGS 
24592  caused  a  significant  increase  (p < 0.05)  in  plasma 
extravasation and wet/dry weight ratios 48 h after SB injury 
as  compared  to  animals  with  SB  injury  alone  (Figures  2 
and  3).  Sham  animals  showed  an  insignificant  increase 
(32%,  p = 0.137)  in  wet/dry  weight  ratio  as  compared  to 
untouched control animals (data not shown). Unexpectedly, 
it was found that NEP antagonist pretreatment also led to 
increased plasma extrasation in uninjured sham animals. 
It is possible that neurogenic inflammation may arise dur-
ing the process of intubation, as wet/dry weight ratios also 
increased in sham animals. Previous studies have indicated 
increased MPO activity following NEP inhibition (Umeno 
et al. 1989; Barbara et al. 2003). The current study further 
substantiates that inhibition of NEP exacerbates SB injury 
as there was a significant increase in MPO activity in CGS 
24592 pretreated animals with SB injury compared to those 
with SB injury alone (Figure 3).
The results of the study can be explained based on the pro-
posed pathway summarized in Figure 1. Chemicals in smoke 
and burn injury stimulate airways towards relatively transient 
neurologic inflammation. When this noxious stimulus is pro-
longed, more epithelial cells will be lost, leading to further 
loss of NEP, plasma extravasation, edema, and inflamma-
tion. Thus the current findings emphasize the importance of 
NEP in the pathogenesis of airway and lung injury following 
combined burn and smoke inhalation injury in mice. It is 
well known that one of the earliest reactions to inhalation of 
cooled cotton smoke in the sheep is detachment of ciliated 
epithelial cells in the trachea. By 48 h after smoke inhalation, 
almost all columnar cells in the trachea and bronchi have 
been lost (Abdi et al. 1990). Since columnar epithelial cells 
are the principal source of neutral endopeptidase in the air-
ways, detachment of columnar cells may lead to loss of much 
of the NEP activity after smoke inhalation injury.
An alternate pathway is based on previous reports from 
this and other laboratories that indicated a delayed lung 
injury  following  smoke  inhalation  (Traber  and  Herndon 
1991;  Speyer  et  al.  2004).  Inflammatory  mediators  are 
thought to increase the release of other chemicals that may 
contribute to tissue injury in different stages of smoke inha-
lation  injury.  They  observed  intense  acute  inflammation 
in the proximal trachea 3 h after injury, and it took many 
more  hours  to  extend  the  injury  to  the  small  peripheral 
airways. The other striking feature of this reaction is that it 
persists for a long time, becoming more severe and affect-
ing a longer segment of the trachea over the course of at 
least 48 h. Therefore, the delayed lung injury may not follow 
a similar pathway compared to that incited by the initial 
noxious stimuli described in Figure 1. Instead there may be 
other mechanisms which continue to stimulate neutrophil 
emigration long after the initial injury, some sort of positive 
feedback loop may be involved, and/or the acute inflam-
matory reaction is not normally terminated.
The most likely sequence of events in the initial induction 
of inflammation is that the chemicals in smoke stimulate 
impulses in sensory and autonomic nerves, which release 
substance  P  and  calcitonin-gene-related  peptide  (CGRP) 
near  the  lining  epithelium  (Lee  and  Widdicombe  2001). 
Concurrent and progressive loss of NEP activity might be 
expected to increase the intensity and duration of the pro-
inflammatory  effects  of  neuropeptides  in  the  airways.  In 
conclusion, our study indicates that inhibition of NEP by 
CGS  24592  would  exacerbate  SB  injury,  leading  to  more 
plasma  extravasation  and  severe  airway  inflammation. 
Further research using large animal models is needed to 
investigate the exfoliation of epithelium and the release of 
CGRP near the lining epithelium as a potential mechanism 
in the pathogenesis of burn and smoke inhalation injury.
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